# HCV Treatment in a Low-threshold Clinic

> **NCT04063839** · — · UNKNOWN · sponsor: **University Hospital, Akershus** · enrollment: 300 (estimated)

## Conditions studied

- Hepatitis C
- Substance Use Disorders

## Interventions

- **DRUG:** Elbasvir / Grazoprevir Oral Tablet

## Key facts

- **NCT ID:** NCT04063839
- **Lead sponsor:** University Hospital, Akershus
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2019-10-31
- **Final completion:** 2022-12
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2019-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04063839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04063839, "HCV Treatment in a Low-threshold Clinic". Retrieved via MORVS 2026-09-29 from https://api.morvs.ai/clinical/NCT04063839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*